NASDAQ:AGIO | Free Cash Flow | AGIOS PHARMACEUTICALS, INC.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2011-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$118.92M$769,000.00-$119.69M
2025-12-31-$96.21M$1.12M-$97.33M
2025-03-31-$111.49M$766,000.00-$112.26M
2024-12-31-$133.17M$967,000.00-$134.13M
2024-03-31-$99.87M$141,000.00-$100.01M
2023-12-31-$72.49M$234,000.00-$72.72M
2023-03-31-$95.18M$399,000.00-$95.58M
2022-12-31-$66.16M$113,000.00-$66.28M-181.45%
2022-03-31-$97.74M$2.8M-$100.54M
2021-12-31-$84.09M$4.5M-$88.6M
2021-03-31-$120.75M$1.01M-$121.76M-6.50%
2020-12-31-$49.4M$562,000.00-$49.96M
2020-03-31-$105.36M$4.2M-$109.55M
2019-12-31-$93.61M$6.68M-$100.29M
2019-03-31-$103.27M$2.04M-$105.31M
2018-12-31-$74.19M$1.05M-$75.24M
2018-03-31-$99M$1.43M-$100.43M
2017-12-31-$74.45M$1.28M-$75.73M
2017-03-31-$74.07M$293,000.00-$74.37M
2016-12-31-$51.22M$1.22M-$52.45M
2016-03-31-$19.01M$2.53M-$21.54M
2015-12-31-$30.53M$2.19M-$32.72M
2015-03-31-$25.59M$3.8M-$29.38M
2014-12-31-$7.78M$1.49M-$9.26M
2014-03-31-$27.04M$13,000.00-$27.05M
2013-12-31-$13.62M$219,000.00-$13.84M
2013-03-31-$11.98M$275,000.00-$12.26M
2012-12-31-$11.63M$26,000.00-$11.66M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$372.98M$4.32M-$377.29M
2024-12-31-$389.84M$1.69M-$391.53M-58.11%
2023-12-31-$296.06M$999,000.00-$297.06M
2022-12-31-$309.48M$4.88M-$314.36M
2021-12-31-$407.32M$5.74M-$413.06M-25.74%
2020-12-31-$290.76M$14.11M-$304.87M
2019-12-31-$370.62M$12.03M-$382.65M
2018-12-31-$304.42M$6.99M-$311.41M
2017-12-31-$285.23M$4.63M-$289.86M
2016-12-31$38.56M$9.92M$28.65M
2015-12-31-$76.95M$20.16M-$97.11M
2014-12-31-$59.35M$2.22M-$61.57M
2013-12-31-$56.4M$1.29M-$57.69M
2012-12-31-$49.55M$1.48M-$51.02M
2011-12-31-$15.22M$1.91M-$17.13M